Filing Details

Accession Number:
0001447362-21-000158
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-09 16:27:24
Reporting Period:
2021-07-07
Accepted Time:
2021-07-09 16:27:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447362 Castle Biosciences Inc CSTL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239501 J Derek Maetzold C/O Castle Biosciences, Inc.
505 S. Friendswood Drive, Suite 401
Friendswood TX 77546
Pres. & Chief Exec. Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-07-07 5,946 $69.69 460,072 No 4 S Direct
Common Stock Disposition 2021-07-07 3,354 $70.38 456,718 No 4 S Direct
Common Stock Disposition 2021-07-07 700 $71.44 456,018 No 4 S Direct
Common Stock Disposition 2021-07-08 600 $66.62 455,418 No 4 S Direct
Common Stock Disposition 2021-07-08 2,599 $68.42 452,819 No 4 S Direct
Common Stock Disposition 2021-07-08 1,597 $69.51 451,222 No 4 S Direct
Common Stock Disposition 2021-07-08 4,504 $70.31 446,718 No 4 S Direct
Common Stock Disposition 2021-07-08 700 $71.01 446,018 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 156,460 Indirect By DJM Grantor Retained Annuity Trust No. 1
Common Stock 179,300 Indirect By The Maetzold Descendants 2020 Trust
Common Stock 166,700 Indirect By Derek Maetzold 2020 Irrevocable Trust
Footnotes
  1. These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 11, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $68.990 to $69.960, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $70.000 to $70.830, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $71.150 to $71.785, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $66.460 to $66.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $67.880 to $68.830, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $68.880 to $69.870, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $69.890 to $70.840, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $70.960 to $71.040, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. Held by DJM Grantor Retained Annuity Trust No. 1 of which the Reporting Person is the trustee and beneficiary.
  11. Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.
  12. Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.